328 related articles for article (PubMed ID: 21029020)
1. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
[TBL] [Abstract][Full Text] [Related]
2. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Nixon DR
J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.
Aptel F; Cucherat M; Denis P
Eur J Ophthalmol; 2012; 22(1):5-18. PubMed ID: 22167538
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
Skorkovská K
Cesk Slov Oftalmol; 2008 Jul; 64(4):144-8. PubMed ID: 18780653
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
Martinez A; Sanchez M
Curr Med Res Opin; 2007 May; 23(5):1025-32. PubMed ID: 17519068
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study.
Centofanti M; Oddone F; Vetrugno M; Manni G; Fogagnolo P; Tanga L; Ferreri P; Rossetti L
Eur J Ophthalmol; 2009; 19(1):66-71. PubMed ID: 19123151
[TBL] [Abstract][Full Text] [Related]
10. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
[TBL] [Abstract][Full Text] [Related]
11. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Eisenberg DL; Toris CB; Camras CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
[TBL] [Abstract][Full Text] [Related]
12. Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.
Curran MP; Orman JS
Drugs Aging; 2009; 26(2):169-84. PubMed ID: 19220073
[TBL] [Abstract][Full Text] [Related]
13. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
[TBL] [Abstract][Full Text] [Related]
15. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
Schwartz GF; Tan J; Kotak S
J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
[TBL] [Abstract][Full Text] [Related]
16. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
[TBL] [Abstract][Full Text] [Related]
18. Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol?
Soto J; Diaz S
Eur J Ophthalmol; 2010; 20(1):246-7; author reply 247-8. PubMed ID: 20047180
[No Abstract] [Full Text] [Related]
19. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
20. Long-term IOP lowering with bimatoprost in open-angle glaucoma patients poorly responsive to latanoprost.
Sonty S; Donthamsetti V; Vangipuram G; Ahmad A
J Ocul Pharmacol Ther; 2008 Oct; 24(5):517-20. PubMed ID: 18800869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
